Back to Search
Start Over
Pro B, Advani R, Brice P, et al. Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma. Blood. 2017;130(25):2709-2717
- Source :
- Blood. 132:458-459
- Publication Year :
- 2018
- Publisher :
- American Society of Hematology, 2018.
- Subjects :
- 0301 basic medicine
Oncology
medicine.medical_specialty
business.industry
Immunology
Cell Biology
Hematology
medicine.disease
Biochemistry
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Refractory
030220 oncology & carcinogenesis
Internal medicine
medicine
In patient
business
Brentuximab vedotin
Anaplastic large-cell lymphoma
medicine.drug
Subjects
Details
- ISSN :
- 15280020 and 00064971
- Volume :
- 132
- Database :
- OpenAIRE
- Journal :
- Blood
- Accession number :
- edsair.doi...........da98aa1debed62ecc596b545fe4dd734
- Full Text :
- https://doi.org/10.1182/blood-2018-05-853192